Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Neoplasms 1Carcinoma, Squamous Cell 1Adenocarcinoma 1

Interventions

Blood Specimen Collection 6Radiotherapy 2Quality of Life 2Phlebotomy 2Interviews as Topic 2Drug Therapy 2zolbetuximab 1trastuzumab deruxtecan 1sargramostim 1pembrolizumab 1iopromide 1capecitabine-irinotecan combination 1X-Rays 1Tumor Burden 1Transurethral Resection of Prostate 1Tomography, X-Ray Computed 1Therapeutics 1Surveys and Questionnaires 1Risedronic Acid 1Registries 1Raloxifene Hydrochloride 1Radiofrequency Ablation 1Radiation, Ionizing 1Radiation 1Positron-Emission Tomography 1Patient Reported Outcome Measures 1Nivolumab 1Molecular Diagnostic Techniques 1Ipilimumab 1Induction Chemotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Adenocarcinoma × Risedronic Acid × Clear all
NCT01077817 2022-02-03

Observational Study of Incidence Rates of Esophageal Cancer in Women Taking Medications for the Prevention or Treatment of Osteoporosis (MK-0217A-352)

Organon and Co

Completed
684,815 enrolled 6 charts
Gastrointestinal

Adenocarcinoma, Carcinoma, Squamous Cell, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡